Plant‐Derived Agents for Counteracting Cisplatin‐Induced Nephrotoxicity

Abstract excerpt

Cisplatin (CSP) is a chemotherapeutic agent commonly used to treat a variety of malignancies. The major setback with CSP treatment is that its clinical efficacy is compromised by its induction of organ toxicity, particular to the kidneys and ears. Despite the significant strides that have been made in understanding the mechanisms underlying CSP-induced renal toxicity, advances in developing renoprotective...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chemotherapy-induced organ toxicity mitigation